4.7 Review

Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 490, 期 1-3, 页码 187-197

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2004.02.056

关键词

CNS complication; type 1 and type 2 diabetes; insulin; C-peptide; hyperglycemia

向作者/读者索取更多资源

Diabetes is an increasingly common disorder which causes and contributes to a variety of central nervous system (CNS) complications which are often associated with cognitive deficits. There appear to be two types of diabetic encephalopathy. Primary diabetic encephalopathy is caused by hyperglycemia and impaired insulin action, which evolves in a diabetes duration-related fashion and is associated with apoptotic neuronal loss and cognitive decline. This appears to be particularly associated with insulin-deficient diabetes. Secondary diabetic encephalopathy appears to arise from hypoxic-ischemic insults due to underlying microvascular disease or as a consequence of hypoglycemia. This type of cerebral diabetic complication is more common in the type 2 diabetic population. Here, we will review the clinical and experimental data supporting this conceptual division of diabetic CNS complications and discuss the underlying metabolic, molecular, and functional aberrations. (C) 2004 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据